Abiomed Inc. clinical trials

Acquired by Johnson & Johnson, Dec 22, 2022 · source ↗

The registry lists 33 studies whose lead sponsor is Abiomed Inc.. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 33 of 33. All Johnson & Johnson studies →

• INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac RecoveryRecruitingNCT06965504Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockRecruitingNCT06964685

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• Abiomed Impella RT-DAQ - Observational StudyRecruitingNCT06308055

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• Impella ECP Study (ECP Study) and Impella ECP Continued Access ProtocolEnrolling by invitationNCT05334784Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Impella Pump Return Study to Analyze Deposits and Biomaterial in Used PumpsRecruitingNCT06765226

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• Impella RP Flex with Smart AssistRecruitingNCT06637644

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• Impella ECP Early Feasibility StudyActive, not recruitingNCT04477603Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• IMpella-Protected cArdiaC Surgery Trial (IMPACT)CompletedNCT05529654Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular FunctionActive, not recruitingNCT04763200Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU TrialActive, not recruitingNCT03947619Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility StudyActive, not recruitingNCT05291884Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• SVC Occlusion in Subjects With Acute Decompensated Heart FailureCompletedNCT03836079Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• IMPACT EU Post-Market Clinical Follow-Up StudyActive, not recruitingNCT05756751Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• V-A ECMO AUTO Mode RegistryCompletedNCT05759377

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• SURPASS Impella 5.5 StudyCompletedNCT05100836

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• The RECOVER IV TrialTerminatedNCT05506449Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Breethe Abiomed Recovery RegisTry (BART)CompletedNCT05473130

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Impella Real-World Surveillance of Patients Using Sodium BicarbonateCompletedNCT05820451

  Sponsor listed in the registry: Abiomed Inc. · First submitted after Abiomed Inc. became part of Johnson & Johnson

• The Smart Pump StudyStatus unknownNCT04465201Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Restore EF Observational StudyCompletedNCT04648306

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• The Global cVAD StudyActive, not recruitingNCT04136392

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• MINI-AMI: Minimizing Infarct Size With Impella 2.5 Following PCI for Acute Myocardial InfarctionTerminatedNCT01319760Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Door To Unloading With IMPELLA CP System in Acute Myocardial Infarction - Safety and Feasibility StudyCompletedNCT03000270Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Protected PCI StudyStatus unknownNCT02831881

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• The Use of Impella RP Support System in Patients With Right Heart FailureStatus unknownNCT01777607Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Investigating the Role of Impella 2.5 System in Acutely Decompensated Chronic Heart Failure PatientsTerminatedNCT01185691Not applicable

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• AbioCor Implantable Replacement HeartNo longer availableNCT00669357

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Voyager I: Patient Discharge Using the AB5000 Portable Driver SystemTerminatedNCT00971776Phase 3

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Symphony: The Implantable Counter Pulsation Device (CPD) Safety and Feasibility TrialStatus unknownNCT01543022Phase 1/2

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Protect II, A Prospective, Multicenter Randomized Controlled TrialTerminatedNCT00562016Phase 3

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• PROTECT I, A Prospective Feasibility Trial Investigating the Use of IMPELLA RECOVER LP 2.5 System in Patients Undergoing High Risk PCICompletedNCT00534859Phase 2

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• Trial Using Impella LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic InstabilityTerminatedNCT00972270Phase 3

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson

• RECOVER I Impella RECOVER LP/LD 5.0 Support System Safety and Feasibility StudyCompletedNCT00596726Phase 2

  Sponsor listed in the registry: Abiomed Inc. · First submitted before Abiomed Inc. became part of Johnson & Johnson